Seeing Is Believing
Currently out of the existing stock ratings of Lee Lueder, 4 are a HOLD (30.77%), 9 are a BUY (69.23%).
Analyst Lee Lueder works with a stock forecast success ratio of 86.11% fulfilled within 81.67 days on average.
Lee Lueder’s has documented 26 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 18-Dec-2023.
Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%) receiving and performance score of 7.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
290
$20.63 (7.66%)
480
11 days ago
5/7 (71.43%)
$27.87 (10.63%)
136
Buy
265
$-4.37 (-1.62%)
1 months 14 days ago
3/3 (100%)
$19.6 (7.99%)
114
Buy
280
$10.63 (3.95%)
250
1 months 14 days ago
2/4 (50%)
$34.6 (14.10%)
128
Buy
268
$-1.37 (-0.51%)
256
1 months 14 days ago
7/9 (77.78%)
$22.6 (9.21%)
95
Buy
245
$-24.37 (-9.05%)
215
3 months 11 days ago
5/6 (83.33%)
$16.91 (7.41%)
66
Which stock is Lee Lueder is most bullish on?
What Year was the first public recommendation made by Lee Lueder?